Inceptor Bio

About:

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.

Website: https://www.inceptor.bio

Top Investors: Kineticos Ventures, Kineticos Disruptor Fund

Description:

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab and manufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.

Total Funding Amount:

$87.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)inceptor.bio

Founders:

Abe Maingi, Shailesh Maingi

Number of Employees:

11-50

Last Funding Date:

2022-10-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai